EFPIA - NEWSLETTER

EFPIA Newsletter 26 January 2023

News

25 January 2023 EFPIA response to medicines shortages reports

EFPIA member companies are not reporting shortages as a result of the situation in China, and where necessary have increased...

25 January 2023 Europe’s cancer community sets out best practice guide to sustainable, equitable and transformative...

Smart investments in cancer care are urgently needed to alleviate demands on healthcare systems and improve access to...

Blogs

23 January 2023 A sustainable environment for a healthy population (Guest Blog)

There is strong agreement between Bengt Mattson and Andreas Haener, chairs of the Interassociation Industry Pharmaceuticals...

26 January 2023 Boosting health in Europeans: Introducing a cardiovascular & diabetes health check

Health Checks are an investment in millions of lives

Events

31 JAN 2023

Even spaceships need a launchpad Virtual event

Bring the regulatory framework for innovative medicines into the future

Learn more →

07 FEB 2023

Impacts of IVDR Implementation on Patient Access to Clinical Trials Online

While the IVDR establishes a new regulatory framework for diagnostic tests in the EU to ensure test accuracy and patient...

Learn more →

08 FEB 2023

Time to act: Building a pharmaceutical framework fit for rare diseases European Parliament, 60 Rue Wiertz, 1047, Bruxelles

Join MEP Stelios Kympouropoulos in discussing the once-in-a-generation revision of the European pharmaceutical framework...

Learn more →

09 FEB 2023

ACCELERATE 2023 Annual Conference Brussels & online

All sessions, including Breakout Sessions, will be available for both in-person and online participants.

Learn more →

What we are reading

Spain will help remind Europe of the lessons of Covid (in Spanish) 24 January 2023 (Cinco Dias | El Pais)

Health brief: Some human, intelligent chats 25 January 2023 (Euractiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶